[Pustulous and erythrodermal psoriasis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000139:chemically induced / Q000188:drug therapy; D003875:Drug Eruptions; D005260:Female; D005672:Fusidic Acid / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010406:Penicillins / Q000009:adverse effects*; D010924:Placental Extracts / Q000009:adverse effects*; D011343:Procaine / Q000009:adverse effects*; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy; D014221:Triamcinolone / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010406:Penicillins; D010924:Placental Extracts; D014221:Triamcinolone; D011343:Procaine; D005672:Fusidic Acid
Psoriasis pustuleux et érythrodermique.